GPP
BIIB icon

Great Point Partners’s Biogen BIIB Stock Holding History

Great Point Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-47,500
Closed -$13.4M – 38
2021
Q3 		$13.4M Buy
47,500
+15,000
+46% +$4.92M 3.13% 13
2021
Q2 		$11.3M Sell
32,500
-42,500
-57% -$12.9M 2.36% 20
2021
Q1 		$21M Buy
+75,000
New +$20.2M 4.34% 11

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Great Point Partners's BIIB Position: Q4 2021 in Review

Great Point Partners sold out of Biogen (BIIB) in Q4 2021, closing a stake of 47,500 shares — an estimated $13.4M sold.

Great Point Partners first reported a position in BIIB in Q1 2021 and held it in 3 quarters. The position peaked at $21M in Q1 2021. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Great Point Partners reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • Great Point Partners sold 47,500 Biogen shares in Q4 2021, an estimated $13.4M.
  • Great Point Partners first reported a position in Biogen in Q1 2021 and held it in 3 quarters.
  • Great Point Partners's Biogen position peaked at $21M in Q1 2021.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Great Point Partners's 13F filing for Q4 2021, filed 14 Feb 2022.